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End-stage renal disease in India and Pakistan: Burden of dis- per capita gross national product (GNP) of $450US and
ease and management issues. In the absence of national regis- $470US, respectively (less than 1.5% of that of the USA),
tries, no reliable data are available on the incidence and preva- both countries fall in the low income group and are classi-lence of end-stage renal disease (ESRD) in India and Pakistan.
fied as “developing countries.” With limited resources andThe incidence of ESRD is likely to be higher than that reported
from the developed world, with chronic glomerulonephritis be- less than 1% of their GNP spent on healthcare, the gov-
ing the most common cause, accounting for more than one third ernments spend most of the allocated funds on more
of patients, while diabetic nephropathy accounts for about one pressing issues such as population control, provision offourth of all patients in India. Patients are generally younger
clean drinking water and sanitation, and the control or(mean age 42 years) at the time of detection of ESRD and two-
thirds first see a nephrologist after they have reached end stage. eradication of communicable diseases. Therefore, it is
Treatment of ESRD is a low priority for the cash-strapped understandable that ESRD care is a low priority for the
public hospitals and in the absence of health insurance plans,
cash strapped governments.less than 10% of all patients receive any kind of renal replace-
Both countries have a dual health care delivery system,ment therapy. The vast majority of patients starting hemodialy-
sis die or stop treatment because of cost constraints within the with the economically less advantaged patients visiting
first three months, and less than 2% patients are started on the state run hospitals and the more affluent population
ambulatory peritoneal dialysis. Although renal transplantation
generally patronizing hospitals in the private sector. Stateis the cheapest option, only about 5% of all patients with ESRD
run hospitals—where consultations are generally freeend up having a transplant. Living related donor transplants
constitute 30 to 40% of all transplants in India, but there is a and dialysis and transplant costs subsidized—are over-
conspicuous gender bias with female donors donating kidneys loaded with patients, with long waiting lists for starting
for their male relatives. Cadaveric transplantation has yet to
dialysis as well as for undergoing transplantation. Statepick up and accounts for less than 2% of all transplants. The
run facilities do not provide maintenance hemodialysisenactment of legislation to regulate renal transplantation in
India has not been able to prevent unrelated (paid) donor for ESRD care, as most dialysis centers are overwhelmed
transplants, which constitute 60 to 70% of all renal transplants. by patients with potentially reversible acute renal failure.Cyclosporine, azathioprine and prednisolone continue to be
As opposed to this, privately run centers readily acceptthe backbone of post-transplant immunosuppression, with
patients on maintenance dialysis programs and have acyclosporine being stopped in a significant proportion at one
year post-transplant to cut down costs. Increasing awareness of short waiting list for transplantation. Furthermore, all
renal disease amongst the population and general practitioners state run hospitals undertake kidney transplants onlycould result in early diagnosis of chronic renal failure and give
from genetically related or spousal kidney donors asopportunity for preventive strategies to delay the onset of
ESRD. Preemptive transplantation and use of generic cyclo- opposed to the private sector where unrelated (and paid)
sporine can help bring down the costs of treatment. Innovative donors are also accepted.
and affordable health insurance policies can also increase the
number of patients who receive effective treatment for ESRD
in these two countries. INCIDENCE AND CAUSES
In the absence of regional or national registries, the
exact incidence of ESRD in both these countries is notCare of patients with end-stage renal disease (ESRD)
known. The reported annual incidence from developingin India and Pakistan, two countries that are home to
countries varies from 34 to 240 per million populationmore than one-sixth of the world’s population, is largely
guided by economic considerations. Having an annual (pmp) [1], which is in contrast to an incidence between
98 and 198 pmp per year reported from ESRD registries
maintained in the developed countries [2]. There is noKey words: chronic renal failure, dialysis, transplantation, developing
countries, renal replacement therapy. reason to believe that the incidence of ESRD will be
lower in India and Pakistan than that reported from the 2003 by the International Society of Nephrology
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Table 1. Causes of ESRD in India and Pakistan kind of RRT. Most patients entering RRT programs in
the country are funded by their employers or by charityIndiaa % Pakistan %
organizations. In a study from a private sector hospitalChronic glomerulonephritis 37 37
Diabetic nephropathy 24 10 in south India, 63% patients belonged to this group, 30%
Chronic interstitial nephritis 14b 19 arranged finances for their treatment by selling property,
Hypertensive nephrosclerosis 13 12
20% raised loans and only 4% were able to take careADPKDc 3.5 3
Multisystem 2.9 — of their treatment costs solely by pooling in family re-
Miscellaneous 1.5 1 sources [6].
Unknown 3.8 18
Data from references 4 and 5.
a Mean age 42  15.6 years DIALYSIS
b Calculus disease in 34%
c Autosomal dominant polycystic kidney disease As compared to 72 dialysis centers in Pakistan (0.5
pmp) [7], there are an estimated 400 dialysis units in
India (0.4 pmp) with about 1000 dialysis stations, more
than two thirds being in the private sector. The annualWest. In contrast, it is likely to be higher, with poor
cost of hemodialysis at private hospitals can vary be-socioeconomic status predisposing the general popula-
tween $2500US/year for twice weekly hemodialysistion to a number of infection related glomerulonephri-
to $3500US/year for thrice weekly hemodialysis. Thistides (GNs) and a relatively higher incidence of nephroli-
along with the cost of 6000 IU/week for erythropoietinthiasis, especially as both countries fall in the “stone
($2500US/year) ensures that the cost of maintenancebelt.” A higher incidence of ESRD has been noted in
hemodialysis is more than ten times the annual per capitaAsians of Indian origin in Birmingham (UK), who com-
GNP and, thus, is out of reach of the vast majority of theprise 14% of the population but 25% of dialysis patients
population. Of the patients who are started on dialysis, 69and 30% of patients on the renal transplant waiting list;
to 71% die on dialysis or stop treatment (due to financialthis is another pointer to the higher incidence of ESRD
reasons), the majority within the first three months ofin this population [3]. Taking a conservative estimate of
initiation of dialysis, and only 17 to 23% patients end upincidence of ESRD at 100/million population/year, and
having a kidney transplant. Of the 8 to 10% who continuea population approaching 1.2 billion in these two coun-
to be on hemodialysis, 60% receive irregular treatments.tries, an estimated 120,000 fresh patients are likely to
Only 2 to 4% are started on continuous ambulatoryreach ESRD in both these countries every year. The prev-
peritoneal dialysis (CAPD) [8, 9]. These data are fromalence figures are likely to be much lower, however, as
centers known for their prolific transplant activity, andmost patients die due to lack of maintenance dialysis.
the overall percentage of ESRD patients undergoing aThe causes of ESRD in India and Pakistan are shown
transplant is therefore likely to be only around 5%.in Table 1, with chronic GN the most common cause
Most public sector hospitals and a majority of the[4, 5]. The mean age of patients entering ESRD programs
private sector dialysis units provide hemodialysis for fourin the subcontinent is much lower (42 years) as compared
hours twice a week using cellulosic membranes. All dial-to the West (61 years) [2]. Therefore, ESRD affects pa-
ysis units reuse dialyzers after manual cleansing andtients in the most productive years of their lives, and
more than 80% of dialysis units continue to use acetatethese patients are often the sole bread earners of their
buffer for hemodialysis. The dialysis prescription is gen-families. The lower mean age of patients with ESRD at
erally empirical with Kt/V 1 in the majority [9].least could be explained in part by the delay in diagnosis
Infections are common in patients on dialysis and areand failure to institute strategies delaying progression of
related to inadequate dialysis, malnutrition, and frequentchronic renal failure (CRF) to ESRD, and by the lower
use of blood transfusions to correct anemia. Together,frequency of diabetic nephropathy due to type 2 diabetes
uremic complications and infections account for 57% ofmellitus.
all deaths in Indian patients on dialysis, with less thanPatients with CRF generally present late in the course
30% of deaths due to ischemic heart disease [9]. Theof their disease, with 66% patients first seeing a nephrol-
prevalence of hepatitis B and C virus infections variesogist when they are already in ESRD. Although in the
between 4 to 12% and 4 to 16%, respectively, in Indiandeveloped and industrialized world, access to renal re-
patients on dialysis and can lead to long-term sequelaeplacement therapy (RRT) is unrestricted and easily
in the post-transplant period.available, patients in India and Pakistan often have to
The last five years have shown an impressive 50%travel long distances to reach a kidney center because
annual growth in the number of CAPD patients in India,of maldistribution of renal services in India, with most
but this growth has not been so marked in Pakistan [7].of the centers located in large cities. Furthermore, be-
It is estimated that there are currently 1500 patients oncause of the virtual absence of health insurance plans,
less than 10% of all patients with ESRD receive any CAPD in India, and until recently most patients were
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using the Y-set. With the very recent establishment of promote cadaveric transplants, there is no such legisla-
tion in Pakistan. However, despite the presence of thisa manufacturing unit indigenously and also weaning off
of Y sets by the industry, most patients on CAPD are legislation, cadaveric donor transplantation has not picked
up and accounts for less than 2% of all transplants thatnow on twin bags. More than two thirds of patients are
on three two-liter exchanges/day and the peritonitis rates are being done. In Pakistan only a handful of cadaveric
kidney transplants have been performed by transplantingare acceptable. Financial constraints prevent wider ac-
ceptability of CAPD, with its annual cost being approxi- organs donated from overseas organ-sharing networks
[5]. The transplant community itself has not done enoughmately $4500US/year for three exchanges per day. Only
a handful of patients can afford a cycler and, therefore, to promote such activity. Lack of infrastructure such as
motorable roads, communications and connectivity bycycler-assisted peritoneal dialysis has yet to make its
presence felt in the sub-continent. air have impeded development of an organized organ-
sharing network at a national level. Although most reli-
gions, including Islam, do not forbid cadaveric organ do-
RENAL TRANSPLANTATION
nation, lack of awareness about brain stem death, short-
Renal transplantation is not only the best form of RRT age of intensive care unit beds, social beliefs and illiteracy
in terms of quality of life after reaching ESRD, it is also are the other obstacles to cadaver organ donation.
the least expensive option if cyclosporine, azathioprine The Human Organ Transplant Act has not had the de-
and prednisolone immunosuppression are used. Success- sired effect on the number of paid unrelated donor trans-
ful renal transplant, therefore, provides the best hope plants, which constitute 60 to 70% of all transplants in
for most patients with ESRD in this region. There are India. ‘Authorisation Committees’ constituted under the
approximately 45 major centers (0.05 pmp) performing Act, which are expected to allow transplantation of an
transplants in India and 12 (0.08 pmp) in Pakistan [5, 7], organ from an unrelated donor only after they are ‘satis-
doing an estimated 3000 and 400 transplants every year, fied’ that the organ donation is solely for altruistic gains
respectively. The cost of renal transplant surgery at a pub- to the donor, have not been effective in controlling this
lic hospital is approximately $1000US only, which will activity.
cover the surgical fees, medications, consumables and in-
patient hospital charges, but the same surgery is likely
PROMISE FOR THE FUTURE?to cost two to three times more at a private center. The
annual cost of cyclosporine and azathioprine immuno- Problems of poverty and malnutrition cannot be easily
solved by the politicians and economists of the regionsuppression is approximately $2500US, and in most in-
stances cyclosporine is tapered and stopped at one year (much less by the nephrologists); however, an increased
level of awareness of renal disease among the populationelectively due to financial reasons. A significant number
of patients stop cyclosporine abruptly because of eco- and general practitioners can result in early diagnosis of
CRF and preventive strategies implemented to delay thenomic constraints and run a higher risk of acute rejection
and graft loss as compared to those with a slow taper. At onset of ESRD. Indigenous manufacture of dialysis ma-
chines and disposables and effective reuse of dialyzersone center in Pakistan a successful transplant program is
being run largely based on donations from non-govern- and tubings can help bring down the costs of hemodialy-
sis. In both countries where majority of the population de-mental charity organizations and individuals, where im-
munosuppressive drugs also are provided free of cost. pends upon state-subsidized hospitals, chronic hemodial-
ysis or CAPD are not likely to be viable large-scale RRTThis successful experiment needs to be copied at more
places in the sub-continent [5]. programs. Renal transplantation thus remains the best
and least expensive option for RRT, and pre-emptive trans-Living related donors constitute 30 to 40% of all kid-
ney donors in India. The type of kidney donors in a state plantation in patients with well-matched related donors
can substantially reduce costs of treatment. Further, usefunded, living-related kidney transplant program has
provided interesting data on the exploitation of females of generic cyclosporine and planned co-administration
of drugs that increase the bioavailability of cyclosporine,as donors in the society. In this study, 37% of all donors
were mothers and the kidney went mostly to the sons coupled with gradual withdrawal of cyclosporine 6 to
12 months after transplantation in patients with haplo-(76%); 29% donors were sisters and 88% of the benefi-
ciaries of these kidneys were brothers. In all 66.4% of matched related donors also can reduce costs of post-
transplant immunosuppression. Cadaveric kidney trans-the donors belonged to the fairer sex, and 83.2% of all
recipients were males [10]. Spouse donors (largely wives) plantation has to be encouraged to provide kidneys to
patients without willing and blood group compatible kid-account for more than 15% of all donors from within
families. ney donors from within their families; however, the higher
costs of post-transplant immunosuppressive drugs re-Although India has the Human Organ Transplant Act
in place since 1994 to regulate transplant activity and to quired for such patients will be a major limiting factor.
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